论文部分内容阅读
目的 :探讨通尿灵和保列治联合治疗前列腺增生症 (BPH)的有效性。方法 :5 4例BPH病人分别给予通尿灵或通尿灵 +保列治联合治疗 8周。结果 :治疗 4周、8周时 ,两治疗组的国际前列腺症状评分 (IPSS)、生活质量评分 (QQL)、最大尿流率 (MFR)均显著改善。 8周时 ,联合治疗组中IPSS减少≥ 2 5 %者占 88.9% ,MFR增加≥ 3ml/s者占 5 1.8% ,而通尿灵治疗 8周时仅为 6 6 .7%和 2 9.6 %、联合治疗 4周时为 6 3 .0 %和 2 9.6 %。结论 :通尿灵和保列治联合治疗能够提高BPH治疗的疗效。
Objective: To explore the effectiveness of Tongluoling and Prism combined treatment of benign prostatic hyperplasia (BPH). Methods: Fifty-four patients with BPH were treated with combination of Tonglu Ling or Tongluiling + Prophylaxis for 8 weeks respectively. Results: IPSS, QQL and MFR were significantly improved in the two treatment groups at 4 weeks and 8 weeks after treatment. At 8 weeks, the IPSS decreased by 25% or 88.9% and the MFR increased by 3ml / s or 5% to 1.8% in the combined treatment group compared with only 6.67% and 22.6% , And the combined treatment was 63.0% and 29.6% at 4 weeks. Conclusion: The combination therapy of Tongluoling and Prism can improve the curative effect of BPH treatment.